The success and applications of cell and gene therapies are seemingly limitless, and economic forecasts project a compound annual growth rate of almost 40% over the next eight years. This rapid expansion is a double edge sword for biomanufacturers of cell and gene therapy products. On the one…
Source: www.genengnews.com – Read more
Why True Healthcare Interoperability Needs AI
Consensus Cloud Solutions’ Johnny Hecker suggests that achieving interoperability in healthcare should involve artificial intelligence (AI) to lower costs for smaller organizations. Rather than implementing
